Analyst Ratings for Fate Therapeutics (FATE )
FATE Rating Summary
FATE Price Target Summary
- Highest: $8.00 (Piper Sandler)
- Lowest: $3.50 (Wells Fargo)
- Average: $6.06
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.06 (+135.9%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
Avg. $ Target:
$6.06 (+135.9%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 44%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/19/2026 | Jefferies | Roger Song | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.73 (2.57) |
48.55% | Details |
| 10/31/2025 | H.C. Wainwright » Updated 7/10/2026 |
Debjit Chattopadhyay | Upgrade | Buy (Neutral) |
7.00 (N/A) |
1.29 (2.57) |
99.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
